Radiomics predicts survival of patients with advanced non‑small cell lung cancer undergoing PD‑1 blockade using Nivolumab-Reference-Cited by-同舟云学术

Radiomics predicts survival of patients with advanced non‑small cell lung cancer undergoing PD‑1 blockade using Nivolumab

Published:2019-12-16 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Nardone Valerio¹,Tini Paolo²,Pastina Pierpaolo²,Botta Cirino³,Reginelli Alfonso⁴,Carbone Salvatore⁵,Giannicola Rocco⁶,Calabrese Grazia⁷,Tebala Carmela⁷,Guida Cesare¹,Giudice Aldo⁸,Barbieri Vito³,Tassone Pierfrancesco³,Tagliaferri Pierosandro³,Cappabianca Salvatore⁴,Capasso Rosanna⁴,Luce Amalia⁴,Caraglia Michele⁴,Mazzei Maria⁵,Pirtoli Luigi²,Correale Pierpaolo⁶

Affiliation:

1. Unit of Radiation Oncology, Integrated Department of Diagnostic Radiology and Radiotherapy, Ospedale del Mare, I‑80147 Naples, Italy

2. Unit of Radiation Oncology, Oncology Department, University Hospital of Siena, I‑53100 Siena, Italy

3. Integrated Area of Medical Oncology, AOU Mater Domini and Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, I‑88100 Catanzaro, Italy

4. Department of Precision Medicine, University of Campania ‘L. Vanvitelli’, I‑80138 Naples, Italy

5. Unit of Medical Imaging, Emergency Department and Diagnostic Services, University Hospital of Siena, I‑53100 Siena, Italy

6. Unit of Medical Oncology, Oncology Department, Grand Metropolitan Hospital ‘Bianchi Melacrino Morelli’ Reggio Calabria I‑89124, Italy

7. Unit of Radiology, Department of Diagnostic Services, Grand Metropolitan Hospital ‘Bianchi Melacrino Morelli’ Reggio Calabria I‑89124, Italy

8. Epidemiology Unit, IRCCS Istituto Nazionale Tumori ‘Fondazione G. Pascale’, I‑80131 Naples, Italy

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial;Clinical Drug Investigation;2024-06-17

2. Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours;Nature Reviews Cancer;2024-06-12

3. A combined model using pre-treatment CT radiomics and clinicopathological features of non-small cell lung cancer to predict major pathological responses after neoadjuvant chemoimmunotherapy;Current Problems in Cancer;2024-06

4. A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?;npj Precision Oncology;2024-02-21

5. Association of PD-1 and PD-L1 protein expression with selected clinical and morphological parameters in colorectal cancers;Polish Journal of Pathology;2024